Physician profile
Steven K Austin
NPI 1518073998
$7,640.20
in general payments reported to CMS, 2019-2025
53 companies · $1,210 in 2025
The $1,210 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $544 · 2020: $776 · 2021: $645 · 2022: $1,348 · 2023: $1,409 · 2024: $1,708 · 2025: $1,210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,326.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,013.33 | 2019-2025 | Farxiga, Wainua, Brilinta |
| Novartis Pharmaceuticals Corporation | $884.15 | 2019-2025 | |
| Medtronic, INC. | $882.26 | 2021-2025 | Onyx Frontier, Linq II, Ffrangio |
| Amgen INC. | $540.30 | 2019-2024 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $427.42 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $352.86 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $256.77 | 2022-2025 | Watchman Flx, Bodyguardian, Watchman Access System |
| Abiomed | $256.71 | 2022-2024 | Impella |
| Shockwave Medical, INC | $237.39 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Kestra Medical Technology Services, INC. | $208.78 | 2025 | Assure Wcd |
| Inari Medical, INC. | $179.60 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Pfizer INC. | $177.24 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $173.94 | 2021-2025 | Verquvo |
| Actelion Pharmaceuticals US, INC. | $170.09 | 2024-2025 | Opsumit, Uptravi, Opsynvi |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $167.33 | 2019-2025 | Lifevest |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Austin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.